Amalgamated Bank purchased a new stake in The Advisory Board Company (NASDAQ:ABCO) during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 5,020 shares of the business services provider’s stock, valued at approximately $235,000.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. First Eagle Investment Management LLC acquired a new position in The Advisory Board during the first quarter valued at $24,907,000. Karp Capital Management Corp acquired a new position in The Advisory Board during the first quarter valued at $244,000. UBS Asset Management Americas Inc. increased its position in The Advisory Board by 132.2% in the first quarter. UBS Asset Management Americas Inc. now owns 21,361 shares of the business services provider’s stock valued at $1,000,000 after buying an additional 12,162 shares during the last quarter. MUFG Securities EMEA plc acquired a new position in The Advisory Board during the first quarter valued at $9,828,000. Finally, Russell Investments Group Ltd. increased its position in The Advisory Board by 195.8% in the first quarter. Russell Investments Group Ltd. now owns 314,234 shares of the business services provider’s stock valued at $14,705,000 after buying an additional 207,990 shares during the last quarter.

The Advisory Board Company (NASDAQ ABCO) traded up 1.08% during trading on Friday, reaching $51.60. 392,722 shares of the company traded hands. The Advisory Board Company has a 52 week low of $24.85 and a 52 week high of $59.50. The firm has a 50-day moving average price of $54.58 and a 200-day moving average price of $49.96. The company has a market capitalization of $2.10 billion, a P/E ratio of 19.60 and a beta of 1.33.

The Advisory Board (NASDAQ:ABCO) last posted its quarterly earnings data on Tuesday, August 8th. The business services provider reported $0.24 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.32 by $0.08. The company had revenue of $200.30 million for the quarter, compared to analyst estimates of $196.16 million. The Advisory Board had a return on equity of 12.69% and a net margin of 13.65%. The business’s revenue was up 1.0% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.46 earnings per share. Analysts forecast that The Advisory Board Company will post $1.89 earnings per share for the current fiscal year.

COPYRIGHT VIOLATION WARNING: This news story was originally reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this news story on another website, it was copied illegally and republished in violation of US and international trademark and copyright legislation. The original version of this news story can be accessed at https://www.thecerbatgem.com/2017/08/19/amalgamated-bank-purchases-new-stake-in-the-advisory-board-company-abco-updated-updated-updated.html.

Several analysts have recently commented on the stock. Robert W. Baird restated an “outperform” rating and set a $65.00 price objective (up from $57.00) on shares of The Advisory Board in a research report on Sunday, July 9th. Zacks Investment Research downgraded shares of The Advisory Board from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, July 25th. BidaskClub downgraded shares of The Advisory Board from a “hold” rating to a “sell” rating in a research report on Saturday, August 5th. Stifel Nicolaus restated a “hold” rating and set a $53.00 price objective (up from $48.00) on shares of The Advisory Board in a research report on Thursday, July 6th. Finally, Credit Suisse Group raised their price objective on shares of The Advisory Board from $54.00 to $55.00 and gave the company an “outperform” rating in a research report on Friday, May 5th. Two equities research analysts have rated the stock with a sell rating, seven have issued a hold rating and six have assigned a buy rating to the company. The company currently has an average rating of “Hold” and an average target price of $51.42.

The Advisory Board Company Profile

The Advisory Board Company is a provider of software and solutions to the healthcare and higher education industries. The Company offers subscription-based membership programs, software and data-enabled services. All of its programs are rooted in best practices and extends across four areas, including Best practices research, Technology, Data-enabled services and Consulting services.

Institutional Ownership by Quarter for The Advisory Board (NASDAQ:ABCO)

Receive News & Stock Ratings for The Advisory Board Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Advisory Board Company and related stocks with our FREE daily email newsletter.